Hengrui Europe Therapeutics Information

Hengrui is the biggest Chinese pharma company with 25’000 employees, headquartered in Shanghai. With strong research focus in oncology, diabetes and metabolic diseases, autoimmune diseases, HIV, it has just started transforming into a global player. In 2020, we established our entities in Europe and USA. We are building a new clinical R&D unit headquartered in Basel, Switzerland. We are also building three pre-clinical labs in Switzerland and England with focus on antibody engineering, mRNA therapeutics and target discovery. We are bringing top European pharma talent to help us build a new exciting international team in the heart of Europe.